Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Lancet Oncol. 2020 Sep;21(9):e431–e443. doi: 10.1016/S1470-2045(20)30323-5

Table 2.

Genomic factors related to radiation responsiveness

Proliferation Ploidy/S-phase studies
Genomic Chromosomal abnormalities e.g., chromosomal loss or amplification, copy number variation (CNV), or translocations
Mutations Tumor burden, specific targeted mutations e.g., TP53 or ATM, or gene-fusions
GWAS Single nucleotide polymorphisms (SNPs)
Transcription Transcriptomics e.g., whole exome, mRNA, miRNA, lncRNA
Epigenome Chromosomal modifications (transcriptome-targeting, or structural) e.g., methylation, acetylation

GWAS = genome wide association studies, lncRNA = long non-coding RNA, mRNA = messenger RNA, miRNA = microRNA